Characterization
of amyloid β (Aβ) oligomers, the transition
species present prior to the formation of Aβ fibrils and that
have cytotoxicity, has become one of the major topics in the investigations
of Alzheimer’s disease (AD) pathogenesis. However, studying
pathophysiological properties of Aβ oligomers is challenging
due to the instability of these protein complexes in vitro. Here, we report that conformation-restricted Aβ42 with an
intramolecular disulfide bond at positions 17 and 28 (SS-Aβ42)
formed stable Aβ oligomers in vitro. Thioflavin
T binding assays, nondenaturing gel electrophoresis, and morphological
analyses revealed that SS-Aβ42 maintained oligomeric structure,
whereas wild-type Aβ42 and the highly aggregative Aβ42
mutant with E22P substitution (E22P-Aβ42) formed Aβ fibrils.
In agreement with these observations, SS-Aβ42 was more cytotoxic
compared to the wild-type and E22P-Aβ42 in cell cultures. Furthermore,
we developed a monoclonal antibody, designated TxCo-1, using the toxic
conformation of SS-Aβ42 as immunogen. X-ray crystallography
of the TxCo-1/SS-Aβ42 complex, enzyme immunoassay, and immunohistochemical
studies confirmed the recognition site and specificity of TxCo-1 to
SS-Aβ42. Immunohistochemistry with TxCo-1 antibody identified
structures resembling senile plaques and vascular Aβ in brain
samples of AD subjects. However, TxCo-1 immunoreactivity did not colocalize
extensively with Aβ plaques identified with conventional Aβ
antibodies. Together, these findings indicate that Aβ with a
turn at positions 22 and 23, which is prone to form Aβ oligomers,
could show strong cytotoxicity and accumulated in brains of AD subjects.
The SS-Aβ42 and TxCo-1 antibody should facilitate understanding
of the pathological role of Aβ with toxic conformation in AD.